Toilet Paper, Minced Meat and Diabetes Medicines: Australian Panic Buying Induced by COVID-19Article Published on 2021-06-292022-10-29 Journal: International Journal of Environmental Research an [Category] Coronavirus, MERS, SARS, [키워드] available data average Care categories Chemical COVID-19 COVID-19 pandemic declining diabete diabetes Government growth health behaviour Health services research health system impacted IMPROVE induced insulin management Medicine Non-communicable disease Number of prescription Pandemics paper Patient patients pharmaceutical prescription public health measure resulting routinely collected health data subsequent toilet Total was obtained [DOI] 10.3390/ijerph18136954 PMC 바로가기 [Article Type] Article
Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical PerspectivesCOVID-19 및 죽상동맥경화증의 염증 기전: 현재의 약학적 관점Review Published on 2021-06-212022-09-12 Journal: International Journal of Molecular Sciences [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-inflammatory agents anti-inflammatory treatment Arrhythmias Atherosclerosis atherosclerotic atherosclerotic heart disease cardiovascular event Cardiovascular events cardiovascular system caused coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 current disease endothelial injury excess mortality heart disease immunomodulator immunomodulators Inflammation inflammatory pathway inflammatory pathways involved Mortality myocardial injury myocarditis pharmaceutical reduction SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe complications similarities similarity systemic inflammatory response thrombotic thrombotic event Treatment Venous Thromboembolism [DOI] 10.3390/ijms22126607 PMC 바로가기 [Article Type] Review
Electron Donor–Acceptor Capacity of Selected Pharmaceuticals against COVID-19Article Published on 2021-06-182022-10-28 Journal: The Cochrane database of systematic reviews [Category] COVID-19, [키워드] Affect antibiotic anticancer antioxidant antiparasitic Antiviral antiviral drug antivirals Capacity clinical study condition contribute coronavirus COVID-19 DAM death defend disease Donor drug drugs effective Efficacy electroaccepting power electron Electron acceptor electron donors explain free radical help Hepatitis hesperidin Infection mechanism MOST New coronavirus new SARS-CoV-2 nine other molecule other molecules Oxidant Oxidation oxidative stress oxidize pandemic pharmaceutical produced radical scavenger reduction Replication Research SARS-CoV2 scavenging sick Spread to define Toxicity treating COVID-19 Treatment treatments for COVID-19 valrubicin viral infection virus [DOI] 10.3390/antiox10060979 PMC 바로가기 [Article Type] Article
Bioinformatics Accelerates the Major Tetrad: A Real Boost for the Pharmaceutical IndustryReview Published on 2021-06-082022-10-29 Journal: International Journal of Molecular Sciences [Category] COVID-19, MERS, [키워드] addressed Analysis approach association bioinformatics COVID-19 database Diagnosis dimension disorders Drug discovery drug side effects genetics Genome sequencing genomic sequencing healthcare information Interpretation Major management manuscript Microbiology microRNA miRNA pandemic pharmaceutical pharmacovigilance promoted proteomics public health Research researcher Stratification Systems biology translational Treatment [DOI] 10.3390/ijms22126184 PMC 바로가기 [Article Type] Review
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial치료 중인 암 환자의 COVID-19 예방에 대한 하이드록시클로로퀸의 효과: 무작위 대조 시험을 위한 연구 프로토콜Update Published on 2021-05-192022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 age assigned blinded Blinding blocks breast and colon cancer calculated Cancer cancer patient Cancer patients Caregivers Colon cancer color company comparator Patients control group Controlled trial coronavirus disease COVID-19 COVID-19 symptom COVID-19 symptoms curative intent Effect examined FIVE follow-up period high resolution Hydroxychloroquine incidence of COVID-19 Intervention investigated Iran leukemia lung Lungs lymphoid Mashhad Medical Sciences Nasopharyngeal swab non-Hodgkin’s lymphoma Novel coronavirus novel coronavirus disease objective occur outcome parallel-group participant Patient patients performed pharmaceutical Pharmaceutical Company Placebo primary end point produced Prophylactic random randomization sequence Randomized controlled trial Randomly receiving regimens RT-PCR Sample Sample size SARS-CoV-2 virus shape Study protocol supplementary material Symptom Tablet the patient tomography total sample size treated Treatment triple-blind two group two groups Two-arm university website [DOI] 10.1186/s13063-021-05292-8 PMC 바로가기 [Article Type] Update
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial culturesCarrageenan 함유 처방전 없이 구입할 수 있는 비강 및 구강 스프레이는 기도 상피 배양물의 SARS-CoV-2 감염을 억제합니다Rapid Report Published on 2021-05-012022-09-10 Journal: American journal of physiology. Lung cellular and [Category] MERS, SARS, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 airway airways Analysis analyzed antiviral activity Antiviral effect carrageenan Cell culture clinical evaluation coronavirus Culture cultures cytotoxic epithelial human airway epithelial in vitro infect Infection inhibit SARS-CoV-2 Intervention limit nasal nasopharyngeal pharmaceutical Pharmaceutical interventions Prevent reduce respiratory risk SARS-CoV-2 SARS-COV-2 infection selected severe acute respiratory syndrome Coronavirus Spread sulfated polysaccharides suppressed TMPRSS2 Transmission Vero E6 Vero E6 cell Viral viral spread virucidal virus infection virus inhibition virus transmission [DOI] 10.1152/ajplung.00552.2020 PMC 바로가기 [Article Type] Rapid Report
Natural resources to control COVID-19: could lactoferrin amend SARS-CoV-2 infectivity?Biochemistry Published on 2021-04-142022-10-28 Journal: PeerJ [Category] COVID-19, [키워드] accumulated asymptomatic patient cells complementary COVID-19 COVID-19 pandemic digestive system effective Evidence immunological in vitro in vivo indicated infection control Innate immunity intestinal lactoferrin limit mechanism multifunctional protein natural peptides pharmaceutical physiological receptor resource Safe SARS-CoV-2 second wave Symptom Symptomatic patients tissue Transmission Treatment Vaccines viral infection [DOI] 10.7717/peerj.11303 PMC 바로가기 [Article Type] Biochemistry
The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution팬데믹과 공급망: 의약품 생산 및 유통의 격차Editorial Published on 2021-04-012022-09-11 Journal: American journal of public health [Category] MERS, 치료제, [키워드] Gap pharmaceutical Production supply [DOI] 10.2105/AJPH.2020.306138 PMC 바로가기 [Article Type] Editorial
Evaluation of the basic assay performance of the GeneSoc ® rapid PCR testing system for detection of severe acute respiratory syndrome coronavirus 2Research Article Published on 2021-03-302022-10-28 Journal: PLoS ONE [Category] COVID-19, SARS, [키워드] acute respiratory syndrome clinical sample Concentration coronavirus coronavirus disease COVID-19 COVID-19 patient Cycling detect detection system Diagnosis displaying evaluate facilitate help implementation infected patients Infection isolate Isolation Japan Laboratory less measure nasopharyngeal swabs pandemic Patient PCR PCR testing pharmaceutical positive Precision RdRP reduce reproducibility SARS-CoV-2 SARS-CoV-2 RNA sensitivity sequence Spread submitted symptomatic Symptoms the patient this system Tokyo Treatment Variation viral envelope virus was performed [DOI] 10.1371/journal.pone.0248397 PMC 바로가기 [Article Type] Research Article
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatmentArticle Published on 2021-03-262022-10-04 Journal: iScience [Category] 비임상, 치료제, [키워드] acute respiratory syndrome anti-inflammatory drug Anti-SARS-CoV-2 Activity Antiviral antiviral activity approved drug binding calculated Cell culture combination treatment combined treatment coronavirus coronavirus disease dose drug candidate drug concentration Efficacy Human immunodeficiency virus inhibit inhibited limit lung Medical Substance nelfinavir pharmaceutical Pharmaceutical Preparation Potential predict predicted proliferation protease inhibition Protease inhibitor Remdesivir required SARS-CoV-2 SARS-CoV-2 entry SARS-CoV-2 replication screened suppressed synergistic target cell target cells Treatment viral clearance viral replication Virology [DOI] 10.1016/j.isci.2021.102367 PMC 바로가기 [Article Type] Article